Here we improved our OBTC technique to unbiasedly screen a large peptoid library for compounds that would bind to a subpopulation of a NSCLC cell line with CSC properties but not to the remainder of the tumor cells from the same cell line, and using these ‘hit’ compounds we identified plectin as a new lung CSC biomarker. This evidence concerns the gene PLEC and neoplasm.